The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma

[11] Benjamin RS(2003)The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma Clin Lab Haematol 25 41-46

[12] Cormier JN(1988)Suppression of lymphokine-activated killer induction by neutrophils J Immunol 141 4395-4402

[13] Pollock RE(2009)Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer J Thorac Cardiovasc Surg 137 425-428

[14] Balkwill F(2012)Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma Anticancer Res 32 1555-1561

[15] Mantovani A(2008)Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 1757-1762

[16] Coussens LM(2015)Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer Am J Surg 209 333-337

[17] Werb Z(2015)Outcome analysis in patients with uterine sarcoma Radiat Oncol J 33 29-35

[18] Crozier JE(2018)Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery J Neuro-Oncol 139 689-697

[19] McKee RF(2012)Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma Cancer 118 1055-1061

[20] McArdle CS(2013)Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients Br J Cancer 109 2316-2322

[11] Benjamin RS(2003)The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma Clin Lab Haematol 25 41-46

[12] Cormier JN(1988)Suppression of lymphokine-activated killer induction by neutrophils J Immunol 141 4395-4402

[13] Pollock RE(2009)Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer J Thorac Cardiovasc Surg 137 425-428

[14] Balkwill F(2012)Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma Anticancer Res 32 1555-1561

[15] Mantovani A(2008)Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 1757-1762

[16] Coussens LM(2015)Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer Am J Surg 209 333-337

[17] Werb Z(2015)Outcome analysis in patients with uterine sarcoma Radiat Oncol J 33 29-35

[18] Crozier JE(2018)Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery J Neuro-Oncol 139 689-697

[19] McKee RF(2012)Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma Cancer 118 1055-1061

[20] McArdle CS(2013)Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients Br J Cancer 109 2316-2322